DNA arrays in clinical oncology: Promises and challenges

Laboratory Investigation

Volumn 83, Issue 3, 2003, Pages 305-316

  Bertucci, François ^a,b   Viens, Patrice ^a,b   Tagett, Rebecca ^c   Nguyen, Catherine ^d   Houlgatte, Rémi ^d   Birnbaum, Daniel ^a,d  

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Ipsogen SA   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ESTROGEN RECEPTOR; MESSENGER RNA;

BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; DNA MICROARRAY; GENE EXPRESSION; GENOMICS; HUMAN; ONCOLOGY; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; SOLID TUMOR;

EID: 0037346250     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000059936.28369.19     Document Type: Short Survey

References (69)

1. Ahr A, Karn T, Solbach C, Seiter T, Strebhardt K, Holtrich U, and Kaufmann M (2002). Identification of high risk breast-cancer patients by gene expression profiling. Lancet 359: 131-132.
2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, and Staudt LM (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511.
3. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, and Korsmeyer SJ (2002). MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30:41-47.
4. Barlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner ML, Torhorst J, Haas P, Bucher C, Sauter G, Kallioniemi OP, and Kallioniemi A (2000). Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst 92:1252-1259.
5. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB, and Hanash S (2002). Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8:816-824.
6. Bertucci F, Bernard K, Loriod B, Chang YC, Granjeaud S, Birnbaum D, Nguyen C, Peck K, and Jordan BR (1999a). Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. Hum Mol Genet 8:1715-1722.
7. Bertucci F, Eisinger F, Houlgatte R, Viens P, and Birnbaum D (2002a). Gene-expression profiling and identification of patients at high risk of breast cancer. Lancet 360:173-174.
8. Bertucci F, Houlgatte R, Benziane A, Granjeaud S, Adelaide J, Tagett R, Loriod B, Jacquemier J, Viens P, Jordan B, Birnbaum D, and Nguyen C (2000). Gene expression profiling of primary breast carcinomas using arrays of candidate genes. Hum Mol Genet 9:2981-2991.
9. Bertucci F, Nasser V, Granjeaud S, Esinger F, Adelaide J, Tagett R, Loriod B, Giaconia A, Benziane A, Devilard E, Jacquemier J, Viens P, Nguyen C, Birnbaum D, and Houlgatte R (2002b). Gene expression profiles of poor-prognosis primary breast cancer correlate with survival. Hum Mol Genet 11:863-872.
10. Bertucci F, Van Hulst S, Bernard K, Loriod B, Granjeaud S, Tagett R, Starkey M, Nguyen C, Jordan B, and Birnbaum D (1999b). Expression scanning of an array of growth control genes in human tumor cell lines. Oncogene 18:3905-3912.
11. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ, and Meyerson M (2001). Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 98:13790-13795.
12. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, and Sondak V (2000). Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536-540.
13. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FCP, Kim IF, Markowitz V, Matese JC, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Ronald Taylor R, Vilo J, and Vingron M (2001). Minimum Information About a Microarray Experiment (MIAME): Toward standards for microarray data. Nat Genet 29:365-371.
14. Brazma A and Vilo J (2000). Gene expression data analysis. FEBS Lett 480:17-24.
15. Chen JJ, Wu R, Yang PC, Huang JY, Sher YP, Han MH, Kao WC, Lee PJ, Chiu TF, Chang F, Chu YW, Wu CW, and Peck K (1998). Profiling expression patterns and isolating differentially expressed genes by cDNA microarray system with colorimetry detection. Genomics 51:313-324.
16. Cheng Q, Lau WM, Tay SK, Chew SH, Ho TH, and Hui KM (2002). Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. Int J Cancer 98:419-426.
17. Clarke PA, te Poele R, Wooster R, and Workman P (2001). Gene expression microarray analysis in cancer biology, pharmacology, and drug development: Progress and potential. Biochem Pharmacol 62:1311-1336.
18. Devilard E, Bertucci F, Trempat P, Bouabdallah R, Loriod B, Giaconia A, Brousset P, Granjeaud S, Nguyen C, Birnbaum D, Birg F, Houlgatte R, and Xerri L (2002). Gene expression profiling defines molecular subtypes of classical Hodgkin's disease. Oncogene 21:3095-3102.
19. Eisen MB, Spellman PT, Brown PO, and Botstein D (1998). Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
20. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, and Liotta LA (1996). Laser capture microdissection. Science 274:998-1001.
21. Fuller GN, Hess KR, Rhee CH, Yung WK, Sawaya RA, Bruner JM, and Zhang W (2002). Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets. Brain Pathol 12:108-116.
22. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI, Altman RB, Brown PO, Botstein D, and Petersen I (2001). Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 98:13784-13789.
23. Gibson UE, Heid CA, and Williams PM (1996). A novel method for real time quantitative RT-PCR. Genome Res 6:995-1001.
24. Ginestier C, Charaffe-Jauffret E, Bertucci F, Elsinger F, Geneix J, Bechlian D, Conte N, Adélaide J, Toiron Y, Nguyen C, Viens P, Moziconacci MJ, Houlgatte R, Birnbaum D, and Jacquemier J (2002). Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers. Am J Pathol 161:1223-1233.
25. Giordano TJ, Shedden KA, Schwartz DR, Kuick R, Taylor JM, Lee N, Misek DE, Greenson JK, Kardia SL, Beer DG, Rennert G, Cho KR, Gruber SB, Fearon ER, and Hanash S (2001). Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 159:1231-1238.
26. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, and Lander ES (1999). Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286:531-537.
27. Gordon GJ, Jensen RV, Hsiao LL, Gullans SR, Blumenstock JE, Ramaswamy S, Richards WG, Sugarbaker DJ, and Bueno R (2002). Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res 62:4963-4967.
28. Granjeaud S, Bertucci F, and Jordan BR (1999). Expression profiling: DNA arrays in many guises. Bioessays 21:781-790.
29. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, Ferno M, Peterson C, and Meltzer PS (2001). Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61:5979-5984.
30. Hofmann WK, de Vos S, Elashoff D, Gschaidmeier H, Hoelzer D, Koeffler HP, and Ottmann OG (2002). Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: A gene-expression study. Lancet 359:481-486.
31. Hoos A and Cordon-Cardo C (2001). Tissue microarray profiling of cancer specimens and cell lines: Opportunities and limitations. Lab Invest 81:1331-1338.
32. Hughes TR, Mao M, Jones AR, Burchard J, Marton MJ, Shannon KW, Lefkowitz SM, Ziman M, Schelter JM, Meyer MR, Kobayashi S, Davis C, Dai H, He YD, Stephaniants SB, Cavet G, Walker WL, West A, Coffey E, Shoemaker DD, Stoughton R, Blanchard AP, Friend SH, and Linsley PS (2001). Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol 19: 342-347.
33. Ince TA and Weinberg RA (2002). Functional genomics and the breast cancer problem. Cancer Cell 1:15-17.
34. Janicke F, Prechtl A, Thomssen C, Harbeck N, Meisner C, Untch M, Sweep CG, Selbmann HK, Graeff H, and Schmitt M (2001). Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1. J Natl Cancer Inst 93:913-920.
35. Kane MD, Jatkoe TA, Stumpf CR, Lu J, Thomas JD, and Madore SJ (2000). Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. Nucleic Acids Res 28:4552-4557.
36. Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM, and Meltzer PS (1998). Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 58:5009-5013.
37. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C, and Meltzer PS (2001). Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 7:673-679.
38. Kihara C, Tsunoda T, Tanaka T, Yamana H, Furukawa Y, Ono K, Kitahara O, Zembutsu H, Yanagawa R, Hirata K, Takagi T, and Nakamura Y (2001). Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 61:6474-6479.
39. Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, and Mok SC (2002). Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA 287:1671-1679.
40. Lawrie LC, Fothergill JE, and Murray GI (2001). Spot the differences: Proteomics in cancer research. Lancet Oncol 2:270-277.
41. Lechner S, Muller-Ladner U, Neumann E, Dietmaier W, Welsh J, Scholmerich J, Ruschoff J, and Kullmann F (2001). Use of simplified transcriptors for the analysis of gene expression profiles in laser-microdissected cell populations. Lab Invest 81:1233-1242.
42. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, and Brown EL (1996). Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14:1675-1680.
43. Luo L, Salunga RC, Guo H, Bittner A, Joy KC, Galindo JE, Xiao H, Rogers KE, Wan JS, Jackson MR, and Erlander MG (1999). Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med 5:117-122.
44. Martin KJ, Graner E, Li Y, Price LM, Kritzman BM, Fournier MV, Rhei E, and Pardee AB (2001). High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood. Proc Natl Acad Sci USA 98:2646-2651.
45. Martin KJ, Kritzman BM, Price LM, Koh B, Kwan CP, Zhang X, Mackay A, O'Hare MJ, Kaelin CM, Mutter GL, Pardee AB, and Sager R (2000). Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res 60:2232-2238.
46. Nadon R and Shoemaker J (2002). Statistical issues with microarrays: Processing and analysis. Trends Genet 18:265-271.
47. Nocito A, Kononen J, Kallioniemi OP, and Sauter G (2001). Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer 94:1-5.
48. O'Dwyer ME and Druker BJ (2000). Status of bcr-abl tyrosine kinase inhibitors in chronic myelogenous leukemia. Curr Opin Oncol 12:594-597.
49. Pegram M, Hsu S, Lewis G, Petras R, Beryt M, Sliwkowski M, Coombs D, Baly D, Kabbinavar F, and Slamon D (1999). Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers. Oncogene 18:2241-2251.
50. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, and Albertson DG (1998). High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211.
51. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, and Golub TR (2002). Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415: 436-442.
52. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, Lander ES, and Golub TR (2001). Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 98:15149-15154.
53. Rimm DL, Camp RL, Charette LA, Costa J, Olsen DA, and Reiss M (2001). Tissue microarray: A new technology for amplification of tissue resources. Cancer J 7:24-31.
54. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, Lopez-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, and Staudt LM (2002). The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346:1937-1947.
55. Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D, and Chinnaiyan AM (2002). Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 287:1662-1670.
56. Schena M, Shalon D, Davis RW, and Brown PO (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467-470.
57. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO, and Weinstein JN (2000). A gene expression database for the molecular pharmacology of cancer. Nat Genet 24: 236-244.
58. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC, and Golub TR (2002). Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 8:68-74.
59. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub TR, and Sellers WR (2002). Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1:203-209.
60. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Haste T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, and Borresen-Dale AL (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874.
61. Staunton JE, Slonim DK, Coller HA, Tamayo P, Angelo MJ, Park J, Scherf U, Lee JK, Reinhold WO, Weinstein JN, Mesirov JP, Lander ES, and Golub TR (2001). Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci USA 98:10787-10792.
62. Su AI, Welsh JB, Sapinoso LM, Kern SG, Dimitrov P, Lapp H, Schultz PG, Powell SM, Moskaluk CA, Frierson HF Jr, and Hampton GM (2001). Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 61:7388-7393.
63. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB, and Teh BT (2001). Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification. Proc Natl Acad Sci USA 98:9754-9759.
64. van't Veer LJ, Dai H, van De Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van Der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, and Friend SH (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536.
65. Velculescu VE, Zhang L, Vogelstein B, and Kinzler KW (1995). Serial analysis of gene expression. Science 270:484-487.
66. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA Jr, Marks JR, and Nevins JR (2001). Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 18:18.
67. Wong KK, Cheng RS, and Mok SC (2001). Identification of differentially expressed genes from ovarian cancer cells by MICROMAX cDNA microarray system. Biotechniques 30: 670-675.
68. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L, and Downing JR (2002). Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1:133-143.
69. Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP, and Johnson PH (2001). Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 61:5168-5178.